Clinical Trial Update: The Effect of Gliatamin (Chonline Alphoscerate) on Depressive Mood in Type 2 Diabetes Patients [Phase 4]

View source ↗

Summary

This document reports a Phase 4 clinical trial evaluating Gliatamin (Choline alfoscerate) for depressive mood in adults with Type 2 diabetes; the study is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Depressive Disorder
• Type 2 Diabetes Mellitus

Drugs mentioned

• Gliatamin (Choline alfoscerate)

Snippet

Sponsor: Yonsei University | Conditions: Type2 Diabetes With Depressive Mood | Phase 4 | Status: RECRUITING